Follow
Rajendra Awasthi
Title
Cited by
Cited by
Year
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
M Mehta, Deeksha, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ...
Chemico-Biological Interactions 308, 206-15, 2019
7512019
The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress
K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ...
Drug development research 80 (6), 714-730, 2019
5312019
Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems
VK Pawar, S Kansal, G Garg, R Awasthi, D Singodia, GT Kulkarni
Drug delivery 18 (2), 97-110, 2011
2552011
Nanoparticles in cancer treatment: opportunities and obstacles
R Awasthi, A Roseblade, PM Hansbro, MJ Rathbone, K Dua, M Bebawy
Current drug targets 19 (14), 1696-1709, 2018
1842018
Lipid nanoparticles as carriers for bioactive delivery
N Dhiman, R Awasthi, B Sharma, H Kharkwal, GT Kulkarni
Frontiers in Chemistry 9, 580118, 2021
1602021
Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems
K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ...
Chemico-biological interactions 299, 168-178, 2019
1162019
Phytosomes: An Approach to Increase The Bioavailability of Plant Extracts
R Awasthi, GT Kulkarni, VK Pawar
International Journal of Pharmacy and Pharmaceutical Sciences 2011 (3), 2, 2011
952011
Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?
R Awasthi, GT Kulkarni
Drug delivery 23 (2), 378-394, 2016
792016
Formation of struvite urinary stones and approaches towards the inhibition—A review
P Das, G Gupta, V Velu, R Awasthi, K Dua, H Malipeddi
Biomedicine & Pharmacotherapy 96, 361-370, 2017
782017
Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for repaglinide
R Awasthi, GT Kulkarni, MV Ramana, TJA Pinto, IS Kikuchi, DDM Ghisleni, ...
International journal of biological macromolecules 97, 721-732, 2017
652017
Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation
S Godara, V Lather, SV Kirthanashri, R Awasthi, D Pandita
Materials Science and Engineering: C 109, 110576, 2020
642020
Development of novel gastroretentive drug delivery system of gliclazide: Hollow beads
R Awasthi, GT Kulkarni
Drug development and industrial pharmacy 40 (3), 398-408, 2014
612014
Berberine: a plant-derived alkaloid with therapeutic potential to combat Alzheimer’s disease
AK Singh, SK Singh, MK Nandi, G Mishra, A Maurya, A Rai, GK Rai, ...
Central Nervous System Agents in Medicinal Chemistry (Formerly Current …, 2019
602019
Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders
AK Singh, B Bhushan, A Maurya, G Mishra, SK Singh, R Awasthi
Dermatologic Therapy 33 (4), e13591, 2020
522020
Molecular mechanisms of action of naringenin in chronic airway diseases
LH Chin, CM Hon, DK Chellappan, J Chellian, T Madheswaran, ...
European journal of pharmacology 879, 173139, 2020
492020
Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation
AK Singh, SS Singh, AS Rathore, SP Singh, G Mishra, R Awasthi, ...
ACS Biomaterials Science & Engineering, 2021
482021
Development of novel gastroretentive floating particulate drug delivery system of gliclazide
R Awasthi, G T Kulkarni
Current drug delivery 9 (5), 437-451, 2012
482012
Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease
AK Singh, SN Rai, A Maurya, G Mishra, R Awasthi, A Shakya, ...
Evidence-Based Complementary and Alternative Medicine 2021, 2021
472021
Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast
JR Madan, S Khobaragade, K Dua, R Awasthi
Dermatologic therapy 33 (3), e13370, 2020
472020
Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection
S Khatak, M Mehta, R Awasthi, KR Paudel, SK Singh, M Gulati, ...
Tuberculosis 125, 102008, 2020
462020
The system can't perform the operation now. Try again later.
Articles 1–20